The Lupus Foundation of America, the national force devoted to solving the cruel mystery of lupus, announced the appointment ...

$48.7 billion for the National Institutes of Health (NIH), a $400 million increase for the largest source of lupus research funding in the world. The bill also provides a $30 million increase in ...

Become a Certified Walk to End Lupus Now Team Captain! Join us on Wednesday, July 30 6:30-7:30pm ET via Zoom Calling all Southeast Region Walk to End Lupus Now Team Captains—whether you're in FL, TN, ...

In serious chronic illnesses such as lupus, palliative care aims to give a person with an illness the best possible quality of life.

The Gary S. Gilkeson Career Development Award was designed for fellows and clinicians with the goal of supporting early career scientists and providing mentorship during a critical time in their lupus ...

The Lupus Foundation of America (LFA) and Lupus Canada are pleased to announce Mohamed Osman, MD, PhD, Associate Professor of ...

A new study found an association between hydroxychloroquine (HCQ) use and early and long-term benefits on kidney function in people with lupus nephritis, (LN, lupus-related kidney disease).

A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), including in people without a diagnosis of lupus nephritis (LN, lupus-related ...

A recent dual-cohort study has found that Lupus Low Disease Activity State (LLDAS) is an attainable and effective treatment target for people with lupus nephritis (LN, lupus-related kidney disease).

The purpose of this study is to establish the safety and potential effectiveness of investigational FT819 in participants with moderate to severe systemic lupus erythematosus (SLE) with or without ...